Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Picconi

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
The Lancet. Neurology|October 1, 2010
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gapPaolo Calabresi, Massimiliano Di Filippo, Veronica Ghiglieri, et al.
Journal of Alzheimer'S Disease : JAD|May 14, 2010
Mitochondria and the link between neuroinflammation and neurodegenerationMassimiliano Di Filippo, Davide Chiasserini, Alessandro Tozzi, et al.
Current Opinion in Pharmacology|October 31, 2006
Plastic abnormalities in experimental Huntington's diseaseMassimiliano Di Filippo, Alessandro Tozzi, Barbara Picconi, et al.
Experimental Neurology|May 10, 2012
Θ-burst stimulation and striatal plasticity in experimental parkinsonismVeronica Ghiglieri, Valentina Pendolino, Carmelo Sgobio, et al.
Experimental Neurology|September 22, 2010
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTPVeronica Ghiglieri, Valentina Pendolino, Vincenza Bagetta, et al.
Parkinsonism & Related Disorders|June 28, 2008
Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSDBarbara Picconi, Veronica Ghiglieri, Vincenza Bagetta, et al.
Neuroscience Letters|March 15, 2006
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinasesMaddalena Napolitano, Barbara Picconi, Diego Centonze, et al.
Journal of Neuroscience Research|September 10, 2019
Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's diseaseVeronica Ghiglieri, Federica Campanelli, Gioia Marino, et al.
Nature Neuroscience|June 29, 2016
Hyperkinetic disorders and loss of synaptic downscalingPaolo Calabresi, Antonio Pisani, John Rothwell, et al.
Neurobiology of Aging|August 9, 2011
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesiasFabrizio Gardoni, Carmelo Sgobio, Valentina Pendolino, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
The Lancet. Neurology|October 1, 2010
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gapPaolo Calabresi, Massimiliano Di Filippo, Veronica Ghiglieri, et al.
Journal of Alzheimer'S Disease : JAD|May 14, 2010
Mitochondria and the link between neuroinflammation and neurodegenerationMassimiliano Di Filippo, Davide Chiasserini, Alessandro Tozzi, et al.
Current Opinion in Pharmacology|October 31, 2006
Plastic abnormalities in experimental Huntington's diseaseMassimiliano Di Filippo, Alessandro Tozzi, Barbara Picconi, et al.
Experimental Neurology|May 10, 2012
Θ-burst stimulation and striatal plasticity in experimental parkinsonismVeronica Ghiglieri, Valentina Pendolino, Carmelo Sgobio, et al.
Experimental Neurology|September 22, 2010
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTPVeronica Ghiglieri, Valentina Pendolino, Vincenza Bagetta, et al.
Parkinsonism & Related Disorders|June 28, 2008
Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSDBarbara Picconi, Veronica Ghiglieri, Vincenza Bagetta, et al.
Neuroscience Letters|March 15, 2006
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinasesMaddalena Napolitano, Barbara Picconi, Diego Centonze, et al.
Journal of Neuroscience Research|September 10, 2019
Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's diseaseVeronica Ghiglieri, Federica Campanelli, Gioia Marino, et al.
Nature Neuroscience|June 29, 2016
Hyperkinetic disorders and loss of synaptic downscalingPaolo Calabresi, Antonio Pisani, John Rothwell, et al.
Neurobiology of Aging|August 9, 2011
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesiasFabrizio Gardoni, Carmelo Sgobio, Valentina Pendolino, et al.
Pageof 14